Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Alcon Laboratories, Inc.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Alcon Laboratories, Inc.

Regulatory records
13
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 13 FDA records to the applicant name Alcon Laboratories, Inc.. The collection includes 1 510(k) clearance. 1 entry is a PMA supplement. 11 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Aug 25, 2025 to Jul 8, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code HQL appears in 9 of the 13 linked filings. The collection spans 3 FDA product codes and 3 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P930014, with 9 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 6201 S. Fwy. Dr., Fort Worth, TX, 76134. Recorded on P930014/S164, decision dated Jul 8, 2026.

Changes described in PMA records

P930014/S161: AcrySof Single-Piece IOL (SA60AT); AcrySof IQ Aspheric IOL (SN60WF); AcrySof Aspheric UV-Absorbing IOL (SA60WF); AcrySof

FDA’s recorded scope: approval application (PMA) 180-day supplement, which requested approval for a new packaging configuration, automation of the primary and secondary packaging processes, and updates to shelf-life and storage conditions of the AcrySof IOLs (storage condition temperatures from 45 °C to 30 °C), and Clareon IOLs (to extend the shelf life from four (4) years to five (5) years at the temperature of 30 °C) in Alcons manufacturing facilities in West Virginia, USA and Cork, Ireland.

Apr 30, 2026 · Normal 180 Day Track

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
Alcon Laboratories, Inc.PMA supplementJul 8, 2026FDA
Alcon Laboratories, Inc.PMA supplementJul 6, 2026FDA
Alcon Laboratories, Inc.PMA supplementJul 2, 2026FDA
Alcon Laboratories, Inc.PMA supplementMay 29, 2026FDA
Alcon Laboratories, Inc.PMA supplementApr 30, 2026FDA
Alcon Laboratories, Inc.PMA supplementMar 11, 2026FDA
Alcon Laboratories, Inc.PMA supplementMar 2, 2026FDA
Alcon Laboratories, Inc.PMA supplementFeb 26, 2026FDA
Alcon Laboratories, Inc.510(k) clearanceFeb 13, 2026FDA
Alcon Laboratories, Inc.PMA supplementFeb 11, 2026FDA
Alcon Laboratories, Inc.PMA supplementDec 12, 2025FDA
Alcon Laboratories, Inc.PMA supplementSep 18, 2025FDA
Alcon Laboratories, Inc.PMA supplementAug 25, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 20, 2026.